182 related articles for article (PubMed ID: 25062737)
1. Interplay between steroid signalling and microRNAs: implications for hormone-dependent cancers.
Fletcher CE; Dart DA; Bevan CL
Endocr Relat Cancer; 2014 Oct; 21(5):R409-29. PubMed ID: 25062737
[TBL] [Abstract][Full Text] [Related]
2. β-arrestin-biased agonism of β-adrenergic receptor regulates Dicer-mediated microRNA maturation to promote cardioprotective signaling.
Teoh JP; Bayoumi AS; Aonuma T; Xu Y; Johnson JA; Su H; Weintraub NL; Tang Y; Kim IM
J Mol Cell Cardiol; 2018 May; 118():225-236. PubMed ID: 29627294
[TBL] [Abstract][Full Text] [Related]
3. Coordinated AR and microRNA regulation in prostate cancer.
Eringyte I; Zamarbide Losada JN; Powell SM; Bevan CL; Fletcher CE
Asian J Urol; 2020 Jul; 7(3):233-250. PubMed ID: 32742925
[TBL] [Abstract][Full Text] [Related]
4. A novel role for GSK3β as a modulator of Drosha microprocessor activity and MicroRNA biogenesis.
Fletcher CE; Godfrey JD; Shibakawa A; Bushell M; Bevan CL
Nucleic Acids Res; 2017 Mar; 45(5):2809-2828. PubMed ID: 27907888
[TBL] [Abstract][Full Text] [Related]
5. β-arrestin1-biased β1-adrenergic receptor signaling regulates microRNA processing.
Kim IM; Wang Y; Park KM; Tang Y; Teoh JP; Vinson J; Traynham CJ; Pironti G; Mao L; Su H; Johnson JA; Koch WJ; Rockman HA
Circ Res; 2014 Feb; 114(5):833-44. PubMed ID: 24334028
[TBL] [Abstract][Full Text] [Related]
6. Effects of treatment with androgen receptor ligands on microRNA expression of prostate cancer cells.
Segal CV; Koufaris C; Powell C; Gooderham NJ
Toxicology; 2015 Jul; 333():45-52. PubMed ID: 25846647
[TBL] [Abstract][Full Text] [Related]
7. miR-21: an androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth.
Ribas J; Ni X; Haffner M; Wentzel EA; Salmasi AH; Chowdhury WH; Kudrolli TA; Yegnasubramanian S; Luo J; Rodriguez R; Mendell JT; Lupold SE
Cancer Res; 2009 Sep; 69(18):7165-9. PubMed ID: 19738047
[TBL] [Abstract][Full Text] [Related]
8. Androgens and estrogens stimulate ribosome biogenesis in prostate and breast cancer cells in receptor dependent manner.
Ray S; Johnston R; Campbell DC; Nugent S; McDade SS; Waugh D; Panov KI
Gene; 2013 Aug; 526(1):46-53. PubMed ID: 23608168
[TBL] [Abstract][Full Text] [Related]
9. The microRNA biogenesis machinery: regulation by steroid hormones and alterations in cancer.
González-Duarte RJ; Cázares-Ordoñez V; Ávila-Chávez E
Rev Invest Clin; 2014; 66(5):460-4. PubMed ID: 25695389
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor-mediated regulation of microRNA inhibits proliferation of vascular smooth muscle cells.
Zhao J; Imbrie GA; Baur WE; Iyer LK; Aronovitz MJ; Kershaw TB; Haselmann GM; Lu Q; Karas RH
Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):257-65. PubMed ID: 23175673
[TBL] [Abstract][Full Text] [Related]
11. The miR-96 and RARγ signaling axis governs androgen signaling and prostate cancer progression.
Long MD; Singh PK; Russell JR; Llimos G; Rosario S; Rizvi A; van den Berg PR; Kirk J; Sucheston-Campbell LE; Smiraglia DJ; Campbell MJ
Oncogene; 2019 Jan; 38(3):421-444. PubMed ID: 30120411
[TBL] [Abstract][Full Text] [Related]
12. MiR-221 expression affects invasion potential of human prostate carcinoma cell lines by targeting DVL2.
Zheng C; Yinghao S; Li J
Med Oncol; 2012 Jun; 29(2):815-22. PubMed ID: 21487968
[TBL] [Abstract][Full Text] [Related]
13. Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.
Jalava SE; Urbanucci A; Latonen L; Waltering KK; Sahu B; Jänne OA; Seppälä J; Lähdesmäki H; Tammela TL; Visakorpi T
Oncogene; 2012 Oct; 31(41):4460-71. PubMed ID: 22266859
[TBL] [Abstract][Full Text] [Related]
14. The microRNA -23b/-27b cluster suppresses the metastatic phenotype of castration-resistant prostate cancer cells.
Ishteiwy RA; Ward TM; Dykxhoorn DM; Burnstein KL
PLoS One; 2012; 7(12):e52106. PubMed ID: 23300597
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs in the development and neoplasia of the mammary gland.
Jena MK
F1000Res; 2017; 6():1018. PubMed ID: 28979765
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer.
Fletcher CE; Sulpice E; Combe S; Shibakawa A; Leach DA; Hamilton MP; Chrysostomou SL; Sharp A; Welti J; Yuan W; Dart DA; Knight E; Ning J; Francis JC; Kounatidou EE; Gaughan L; Swain A; Lupold SE; de Bono JS; McGuire SE; Gidrol X; Bevan CL
Oncogene; 2019 Jul; 38(28):5700-5724. PubMed ID: 31043708
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA and cancer--focus on apoptosis.
Wang Y; Lee CG
J Cell Mol Med; 2009 Jan; 13(1):12-23. PubMed ID: 19175697
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs and the regulation of aldosterone signaling in the kidney.
Butterworth MB
Am J Physiol Cell Physiol; 2015 Apr; 308(7):C521-7. PubMed ID: 25673770
[TBL] [Abstract][Full Text] [Related]
19. SMAD proteins control DROSHA-mediated microRNA maturation.
Davis BN; Hilyard AC; Lagna G; Hata A
Nature; 2008 Jul; 454(7200):56-61. PubMed ID: 18548003
[TBL] [Abstract][Full Text] [Related]
20. microRNAs and DICER1 are regulated by 1,25-dihydroxyvitamin D in prostate stroma.
Dambal S; Giangreco AA; Acosta AM; Fairchild A; Richards Z; Deaton R; Wagner D; Vieth R; Gann PH; Kajdacsy-Balla A; Van der Kwast T; Nonn L
J Steroid Biochem Mol Biol; 2017 Mar; 167():192-202. PubMed ID: 28089917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
